HK1198921A1 - 包含 和/或 的抗微生物組合物及其使用方法 - Google Patents

包含 和/或 的抗微生物組合物及其使用方法

Info

Publication number
HK1198921A1
HK1198921A1 HK14112445.0A HK14112445A HK1198921A1 HK 1198921 A1 HK1198921 A1 HK 1198921A1 HK 14112445 A HK14112445 A HK 14112445A HK 1198921 A1 HK1198921 A1 HK 1198921A1
Authority
HK
Hong Kong
Prior art keywords
ohepa
hetre
dgla15
dgla
methods
Prior art date
Application number
HK14112445.0A
Other languages
English (en)
Inventor
Jonathan Rowe
David Coughlan
Mehar Manku
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1198921A1 publication Critical patent/HK1198921A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK14112445.0A 2012-01-26 2014-12-10 包含 和/或 的抗微生物組合物及其使用方法 HK1198921A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261591036P 2012-01-26 2012-01-26
US13/478,990 US20120264705A1 (en) 2012-01-26 2012-05-23 Antimicrobial compositions comprising 15-hetre and methods of use thereof
PCT/US2013/023201 WO2013112876A1 (en) 2012-01-26 2013-01-25 Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof

Publications (1)

Publication Number Publication Date
HK1198921A1 true HK1198921A1 (zh) 2015-06-19

Family

ID=47006834

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14112445.0A HK1198921A1 (zh) 2012-01-26 2014-12-10 包含 和/或 的抗微生物組合物及其使用方法

Country Status (16)

Country Link
US (2) US20120264705A1 (zh)
EP (1) EP2806868A4 (zh)
JP (3) JP6557009B2 (zh)
KR (1) KR20140117379A (zh)
CN (1) CN104114166A (zh)
AU (1) AU2013211982A1 (zh)
BR (1) BR112014018421A8 (zh)
CA (1) CA2857046A1 (zh)
HK (1) HK1198921A1 (zh)
IL (1) IL232777A0 (zh)
MX (1) MX2014006947A (zh)
PH (1) PH12014501693A1 (zh)
RU (1) RU2014134720A (zh)
SG (1) SG11201404088TA (zh)
WO (1) WO2013112876A1 (zh)
ZA (1) ZA201403948B (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US9855236B2 (en) 2011-10-19 2018-01-02 Ds Biopharma Limited Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof
US8293790B2 (en) * 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
CN104010637A (zh) * 2011-10-19 2014-08-27 尊贵科学有限公司 含有双同-γ-次亚麻油酸及/或15-羟基二十碳三烯酸的药物组合物及其使用方法
GB201301626D0 (en) * 2013-01-30 2013-03-13 Dignity Sciences Ltd Composition comprising 15-OHEPA and methods of using the same
GB201307082D0 (en) * 2013-04-19 2013-05-29 Dignity Sciences Ltd Pharmaceutical composition comprising 15-HETrE and methods of using the same
US20150080329A1 (en) * 2013-09-19 2015-03-19 Dignity Sciences Limited Pharmaceutical compositions comprising dha, epa, and/or gla and an antibiotic agent and methods of use thereof
WO2015071766A1 (en) 2013-11-15 2015-05-21 Dignity Sciences Limited Pharmaceutically acceptable salts of polyunsaturated hydroxy fatty acids
US20150196521A1 (en) * 2014-01-10 2015-07-16 Dignity Sciences Limited Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same
SG10201912145VA (en) 2014-06-04 2020-02-27 Dignity Sciences Ltd Pharmaceutical compositions comprising dgla and use of same
LT6177B (lt) 2014-10-10 2015-07-27 Uab "Biocentras" Fermentų kompleksų išskyrimas iš steptomyces gougerotii 101, daugiafermentinių biopreparatų ruošimas bei taikymas
MA41120A (fr) 2014-12-02 2017-10-10 Afimmune Ltd Compositions comprenant le 15-hepe et méthodes de traitement ou de prévention de la fibrose à l'aide de celles-ci
CN107405324A (zh) * 2015-01-16 2017-11-28 艾菲穆恩有限公司 包含15‑hepe的组合物和其使用方法
EP3325094B1 (en) 2015-07-21 2021-01-06 Afimmune Limited Compositions comprising 15(s)-hepe for use in sensitizing cancer cells to radiation therapy
KR20200055154A (ko) * 2015-12-18 2020-05-20 애피뮨 리미티드 15-hepe를 포함하는 조성물 및 이를 사용하는 방법
MX2020002157A (es) 2017-08-30 2020-07-20 Unilever Ip Holdings B V Una composicion para el cuidado personal.
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344930A (en) * 1975-10-30 1982-08-17 Colgate-Palmolive Company Skin care sponge
JP4926310B2 (ja) * 1996-02-15 2012-05-09 エルテーベー４・スウェーデン・アクチェボラーグ 抗ウイルス薬および抗腫瘍薬としてのロイコトリエンｂ４またはその類似体の使用
US5789441A (en) * 1996-02-15 1998-08-04 Virocell Inc. Leukotriene B4 as an antiviral and anti-neoplastic agent
US6190645B1 (en) * 1999-07-15 2001-02-20 Playtex Products, Inc. Sunscreen for the scalp hair and hair
US20030073930A1 (en) * 2001-10-17 2003-04-17 Morrissey Gerald R. Methods and device for preventing or healing injured nipples or areolas in mammalian females or for obtaining samples from nipples in mammalian females
US20030105445A1 (en) * 2001-11-30 2003-06-05 Kimberly-Clark Worldwide, Inc. Breast pad assembly containing a skin benefit ingredient
WO2005102309A2 (en) * 2004-04-26 2005-11-03 Ltb4 Sweden Ab In vivo release of endogenous anti-microbial mediators by leukotriene b4 (ltb4) administration
CN101426914A (zh) * 2005-12-30 2009-05-06 因特拉迪格姆公司 促进皮肤的无疤痕伤口痊愈的siRNA组合物以及用于伤口治疗的方法
CN101594788A (zh) * 2006-11-23 2009-12-02 卡吉尔公司 化学改性淀粉的天然等价物
EP2155251B1 (en) * 2007-05-08 2013-09-25 Rq Bioscience, Inc. Therapeutic compositions and methods for treating gram-negative bacterial infections
EP2159732A1 (en) * 2008-08-21 2010-03-03 Thomson Licensing Method and device for code obfuscation
GB0907413D0 (en) * 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8637298B2 (en) * 2009-06-16 2014-01-28 E I Du Pont De Nemours And Company Optimized strains of yarrowia lipolytica for high eicosapentaenoic acid production
US8293790B2 (en) * 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof

Also Published As

Publication number Publication date
AU2013211982A1 (en) 2014-06-19
WO2013112876A1 (en) 2013-08-01
KR20140117379A (ko) 2014-10-07
US20140171358A1 (en) 2014-06-19
US20120264705A1 (en) 2012-10-18
BR112014018421A2 (zh) 2017-06-20
ZA201403948B (en) 2015-12-23
JP2020023513A (ja) 2020-02-13
JP2018065818A (ja) 2018-04-26
JP2015504921A (ja) 2015-02-16
BR112014018421A8 (pt) 2017-07-11
JP6557009B2 (ja) 2019-08-07
RU2014134720A (ru) 2016-03-20
CN104114166A (zh) 2014-10-22
PH12014501693A1 (en) 2014-10-20
SG11201404088TA (en) 2014-10-30
MX2014006947A (es) 2015-03-05
CA2857046A1 (en) 2013-08-01
IL232777A0 (en) 2014-07-31
EP2806868A1 (en) 2014-12-03
EP2806868A4 (en) 2015-08-26

Similar Documents

Publication Publication Date Title
HK1198921A1 (zh) 包含 和/或 的抗微生物組合物及其使用方法
IL250824A0 (en) Certain amino-pyrimidines, their assemblies, and methods of using them
HUE048666T2 (hu) Mezõgazdasági endofita-növény kompozíciók és alkalmazási eljárások
IL238958A0 (en) Glutamase inhibitors, preparations containing them and their uses
IL238959A0 (en) Glutamase inhibitors, preparations containing them and their uses
HK1202415A1 (zh) 包括 、和/或 的藥物組合物及其使用方法
EP2763665A4 (en) ANTIMICROBIAL COMPOSITIONS AND METHODS USING SAME
SG11201507867RA (en) Antimicrobial compositions and methods of use
IL234991A0 (en) Preparations containing substances that suppress masp and their uses
HK1215657A1 (zh) 抗微生物組合物及相關使用方法
EP3065547A4 (en) Biscationic and triscationic amphiles as antimicrobial agents
PL2981600T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń i ich wytwarzanie
EP2883549A4 (en) ANTIMICROBIAL COMPOSITION WITH FILOBASIDIUM FOR SUPPRESSING MEDICAMENTS OBTAINED FROM A NATURAL SUBSTANCE
PL2841549T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
PL2841548T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
EP2953455A4 (en) ANTIMICROBIAL COMPOSITIONS, WIPES AND METHODS
ZA201402820B (en) Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
EP2753341A4 (en) ANTIMICROBIAL COMPOSITIONS AND USES THEREOF
PL2961822T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
EP2879670A4 (en) ANTIBACTERIAL COMPOSITIONS AND METHOD
EP2807256A4 (en) MYONECTIN (CTRP15), COMPOSITION COMPRISING SAME AND METHODS OF USE
IL233682A0 (en) Modified phenylazole derivatives, preparations containing them and their uses
EP2967055A4 (en) BIOCIDAL COMPOSITIONS, METHODS OF MAKING, AND METHODS OF USE
PL2989192T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
EP2800568A4 (en) COMPOSITIONS, USE METHOD AND TREATMENT METHOD THEREFOR